Acepodia Stock

www.acepodia.comHealthcare / BioTech & PharmaFounded: 2014

Acepodia, founded in 2016, is a clinical-stage biotechnology company that develops cell therapies aiming to treat cancer patients. Through its unique Antibody-Cell Conjugation (ACC) technology that links tumor-targeting antibodies to immune effector cells, the company aims to improve outcomes for cancer patients due to broad accessibility and effectiveness of the treatments. Acepodia is headquartered in Alameda, California.

Register To Buy and Sell Shares

For more details on financing and valuation for Acepodia, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Acepodia’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Acepodia.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Acepodia investors also invested in these private companies

Team

Management Team

Sonny Hsiao Ph.D
Co-Founder, Chief Executive Officer, Chief Scientific Officer & President
Jennifer Wang Ph.D
Chief Operating Officer & Vice President, Quality
Harry Lam Ph.D
Chief Technical Officer & Executive Vice President of Technical Operations
Patrick Yang Ph.D
Co-Founder

Board Members

Elona Baum
DEFTA Partners

Frequently Asked Questions About Acepodia’s Stock

plusminus
Can you buy Acepodia’s stock?
Acepodia is not publicly traded on NYSE or NASDAQ in the U.S. To buy Acepodia’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Acepodia’s stock?
Yes, you can sell stock of a private company like Acepodia. Forge can help you sell your Acepodia stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is Acepodia’s stock price?
Acepodia is a privately held company and therefore does not have a public stock price. However, you may access Acepodia’s private market stock price with Forge Data.
plusminus
What is Acepodia’s stock ticker symbol?
Acepodia does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Acepodia picks up strong hand to advance cell therapies in $100M series D
Acepodia is ready to ante up its bet on cell therapy after turning over a brand new $100 million series D financing that will support the biotech's pipeline of medicines for solid tumors and hematological cancers.
Updated on: May 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.